Meijer L - Search Results

1

CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells.

Delehouzé C, Godl K, Loaëc N, Bruyère C, Desban N, Oumata N, Galons H, Roumeliotis TI, Giannopoulou EG, Grenet J, Twitchell D, Lahti J, Mouchet N, Galibert MD, Garbis SD, Meijer L. Delehouzé C, et al. Among authors: meijer l. Oncogene. 2014 Dec 11;33(50):5675-87. doi: 10.1038/onc.2013.513. Epub 2013 Dec 9. Oncogene. 2014. PMID: 24317512 Free PMC article.

2

Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.

Damiens E, Baratte B, Marie D, Eisenbrand G, Meijer L. Damiens E, et al. Among authors: meijer l. Oncogene. 2001 Jun 28;20(29):3786-97. doi: 10.1038/sj.onc.1204503. Oncogene. 2001. PMID: 11439342

3

p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.

Knockaert M, Lenormand P, Gray N, Schultz P, Pouysségur J, Meijer L. Knockaert M, et al. Among authors: meijer l. Oncogene. 2002 Sep 19;21(42):6413-24. doi: 10.1038/sj.onc.1205908. Oncogene. 2002. PMID: 12226745

4

Pharmacological inhibitors of cyclin-dependent kinases.

Knockaert M, Greengard P, Meijer L. Knockaert M, et al. Among authors: meijer l. Trends Pharmacol Sci. 2002 Sep;23(9):417-25. doi: 10.1016/s0165-6147(02)02071-0. Trends Pharmacol Sci. 2002. PMID: 12237154 Review.

5

Roscovitine and other purines as kinase inhibitors. From starfish oocytes to clinical trials.

Meijer L, Raymond E. Meijer L, et al. Acc Chem Res. 2003 Jun;36(6):417-25. doi: 10.1021/ar0201198. Acc Chem Res. 2003. PMID: 12809528 Review.

6

Isolation of drugs active against mammalian prions using a yeast-based screening assay.

Bach S, Talarek N, Andrieu T, Vierfond JM, Mettey Y, Galons H, Dormont D, Meijer L, Cullin C, Blondel M. Bach S, et al. Among authors: meijer l. Nat Biotechnol. 2003 Sep;21(9):1075-81. doi: 10.1038/nbt855. Epub 2003 Aug 10. Nat Biotechnol. 2003. PMID: 12910243

7

Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins.

Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager GL, Nagy SR, Han D, Denison M, Ffrench M, Ryan XP, Magiatis P, Polychronopoulos P, Greengard P, Skaltsounis L, Meijer L. Knockaert M, et al. Among authors: meijer l. Oncogene. 2004 May 27;23(25):4400-12. doi: 10.1038/sj.onc.1207535. Oncogene. 2004. PMID: 15077192

8

Cyclin-dependent kinase inhibitor indirubin-3'-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies.

Duensing S, Duensing A, Lee DC, Edwards KM, Piboonniyom SO, Manuel E, Skaltsounis L, Meijer L, Münger K. Duensing S, et al. Among authors: meijer l. Oncogene. 2004 Oct 28;23(50):8206-15. doi: 10.1038/sj.onc.1208012. Oncogene. 2004. PMID: 15378001

9

Roscovitine targets, protein kinases and pyridoxal kinase.

Bach S, Knockaert M, Reinhardt J, Lozach O, Schmitt S, Baratte B, Koken M, Coburn SP, Tang L, Jiang T, Liang DC, Galons H, Dierick JF, Pinna LA, Meggio F, Totzke F, Schächtele C, Lerman AS, Carnero A, Wan Y, Gray N, Meijer L. Bach S, et al. Among authors: meijer l. J Biol Chem. 2005 Sep 2;280(35):31208-19. doi: 10.1074/jbc.M500806200. Epub 2005 Jun 23. J Biol Chem. 2005. PMID: 15975926 Free article.

10

Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives.

Tang L, Li MH, Cao P, Wang F, Chang WR, Bach S, Reinhardt J, Ferandin Y, Galons H, Wan Y, Gray N, Meijer L, Jiang T, Liang DC. Tang L, et al. Among authors: meijer l. J Biol Chem. 2005 Sep 2;280(35):31220-9. doi: 10.1074/jbc.M500805200. Epub 2005 Jun 28. J Biol Chem. 2005. PMID: 15985434 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

476 results

Search Page